CVS Health Corp (CVS)
$74.20 0.61 (0.83%)
8:02 EST CVS Stock Quote Delayed 15 Minutes
Previous Close $73.59
Market Cap 75.44B
PE Ratio 11.40
Volume (Avg. Vol.) 3,228
Day's Range 73.59 - 73.59
52-Week Range 51.72 - 77.03
Dividend & Yield 2.00 (2.70%)
CVS Stock Predictions, Articles, and CVS Health Corp News
- From InvestorPlace
- From the Web
Despite strong quarterly results, there is likely to be short-term profit-taking in CVS stock.
Ever since yields started breaking out higher in early September, value stocks have been on a tear, and this rally won't end anytime soon.
CVS remains a solid dividend stock. But as the U.S. enters an election year, the industry will face uncertainty that will dampen growth.
Options trading was hot in International Business Machines, CVS Health and Square on Wednesday. Here’s what the data suggests moving forward.
CVS stock price has rallied since August. Should investors buy or sell CVS stock before it reports earnings on Nov. 6?
Over the years, CVS stock has limped along. But this could be setting up an opportunity for investors. For the most part, CVS is well positioned to benefit from the changes in healthcare.
If there’s a stakeholder lightning rod, BlackRock (NYSE:BLK) CEO Larry Fink would have to be it.
These hot stocks are in the midst of impressive turnarounds over the past several months, and deserve your attention.
Low P/E stocks often are cheap stocks for a reason. But these 10 stocks to buy have not just reasonable valuations, but strong bull cases.
Positive momentum in these three stocks over the last several months is likely to continue in the quarters ahead, too
RAD stock looks tempting here in the midst of this lull, but what Rite Aid needs to do the most is the one thing that will be toughest to do.
Seemingly every day, the fundamentals surrounding the U.S. economy seem to deteriorate. Nevertheless, these services-related stocks to buy offer a contrarian way to profit from the weakness.
These five stable stocks pay big and sustainable dividends in a world where the "income" part of fixed income is disappearing.
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
These 10 stocks don't quite qualify as "set it and forget it" plays. All have some degree of risk. But the risks seem worth taking for the potential rewards, which include near-term income, longer-term growth, and potential capital appreciation.
These 10 undervalued stocks won't stay undervalued for long, and all 10 are on the verge of big breakout rallies.
Heyward Donigan isn't the reason RAD stock has tanked of late. But, if she doesn't appreciate where Rite Aid is wasting money, she may be the reason Rite Aid stock continues to lose ground.
Navellier RatingsPowered by Portfolio Grader